Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| (NASDAQ: PRME) | Delayed: 3.50 +0.29 (9.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $21.72 | |||
| Open | $3.56 | 52 Week Low | $18.36 | |||
| Day High | $3.72 | P/E | N/A | |||
| Day Low | $3.26 | EPS | $0.00 | |||
| Volume | 8,014,338 | |||||
